Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
32 hedge funds and large institutions have $248M invested in Inhibrx, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$96.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$38.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.6M |
| 4 |
TCM
Tybourne Capital Management
Hong Kong
|
+$19.9M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$18.2M |
Top Sellers
INBX Hedge Fund Activity: Q3 2020 in Review
32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q3 2020, worth a combined $248M.
Buyers outnumbered sellers: 32 funds opened new INBX positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $96.1M.
- 32 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $248M of Inhibrx, Inc. Common Stock stock for Q3 2020.
- 32 funds opened new Inhibrx, Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +32 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q3 2020 was Viking Global Investors, an estimated $96.1M added.
Based on aggregated 13F filings for Q3 2020.